Global Platelet Rich Plasma Market Share

Statistics for the 2023 & 2024 Global Platelet Rich Plasma market share, created by Mordor Intelligence™ Industry Reports. Global Platelet Rich Plasma share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Biotechnology Research Biotechnology R&D Research Life Science Research Technologies Research Cytology Research PRP Industry Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Global Platelet Rich Plasma Industry

The market is moderately competitive with few key players. Some key market players include Arthrex Inc., Cambryn Biologics LLC, China Biologic Products Inc., DePuy Synthes, Dr. PRP USA LLC, EmCyte Corporation, Glofinn Oy, T-Biotechnology, Terumo BCT Inc., and Zimmer Biomet. With the advancement in technology, new players are expected to enter the market.

Platelet-Rich Plasma (PRP) Market Leaders

  1. EmCyte Corporation

  2. Zimmer Biomet

  3. Johnson & Johnson (DePuy Synthes)

  4. Arthrex Inc.

  5. Terumo BCT Inc.

*Disclaimer: Major Players sorted in no particular order

Platelet-Rich Plasma Market Concentration

Platelet Rich Plasma (PRP) Market Report Snapshots

Platelet Rich Plasma Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)